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Ribonucleotide reductases (RNRs) provide the
precursors for DNA biosynthesis and repair and are
successful targets for anticancer drugs such as
clofarabine and gemcitabine. Recently, we reported
that dATP inhibits E. coli class Ia RNR by driving
formation of RNR subunits into a4b4 rings. Here, we
present the first X-ray structure of a gemcitabine-
inhibited E. coli RNR and show that the previously
described a4b4 rings can interlock to form an unprec-
edented (a4b4)2 megacomplex. This complex is also
seen in a higher-resolution dATP-inhibited RNR
structure presented here, which employs a distinct
crystal lattice from that observed in the gemcita-
bine-inhibited case. With few reported examples of
protein catenanes, we use data from small-angle
X-ray scattering and electron microscopy to both
understand the solution conditions that contribute
to concatenation in RNRs as well as present a mech-
anism for the formation of these unusual structures.
INTRODUCTION
The prototyptic class Ia ribonucleotide reductase (RNR) from
E. coli, which is essential for DNA biosynthesis and repair,
employs two subunits, a2 and b2, that perform radical-based
chemistry to convert ribonucleotides to deoxyribonucleotides.
The b2 subunit houses the diferric-tyrosyl radical cofactor used
to initiate radical chemistry, while a2 contains catalytic and regu-
latory sites (Figure 1). Prior to each round of catalysis, a radical
transfer occurs in which the radical moves an unprecedented
35 A˚ from b2 to the catalytic site in the a2 subunit, generating
the essential catalytic thiyl radical (Uhlin and Eklund, 1994;
Seyedsayamdost et al., 2007; Licht et al., 1996). Although
RNRs are successful targets for anticancer drugs such as clofar-
abine and gemcitabine (Hertel et al., 1990; Huang et al., 1991;1374 Structure 20, 1374–1383, August 8, 2012 ª2012 Elsevier Ltd AlPlunkett et al., 1997; Bonate et al., 2006; Zhenchuk et al.,
2009; Gandhi and Plunkett, 2006), there is surprisingly little
structural information depicting holoRNRs (containing both
subunits) with or without these anticancer drugs. Here we
present two crystal structures of inhibited forms of holoRNR
from E. coli: the first structure of a gemcitabine-diphosphate
(F2CDP) inactivated holocomplex to 4.45 A˚ resolution and the
highest resolution structure of a dATP-inhibited RNR, improving
the resolution from 5.65 A˚ (Ando et al., 2011) to 3.95 A˚.
F2CDP is a mechanism-based inhibitor of both E. coli and
human RNR that binds and reacts at the catalytic site and irre-
versibly inhibits a2 using only one equivalent of F2CDP per dimer.
After reaction with the inhibitor, one a per a2 dimer becomes
covalently modified by the sugar of F2CDP (van der Donk
et al., 1998; Wang et al., 2007). Size exclusion experiments indi-
cated that reaction with the drug results in a stabilized complex
of the two subunits not seen in the presence of other substrates
or effectors (Wang et al., 2007), motivating our use of this inhib-
itor in crystallization experiments. In contrast to the chemother-
apeutic agent F2CDP, dATP is a physiological and reversible
inhibitor of RNR, responsible for downregulating activity in the
presence of excess deoxynucleotides (Larsson and Reichard,
1966a, 1966b; Brown and Reichard, 1969). dATP exerts its effect
by binding to the activity site on a2 and shifting the conforma-
tional equilibrium away from an active a2b2 state toward an
inactive a4b4 state (Ando et al., 2011; Rofougaran et al., 2008)
(Figure 1). Accompanying this oligomeric state change is a
dramatic movement of the b2 subunit, which swings from a posi-
tion docked with a2 to a position almost 40 A˚ away, forming
connections with another a2 subunit and leading to formation
of a ring-like a4b4 structure (Figure 1). In the resulting a4b4 struc-
ture, the radical transfer pathway is completely abrogated (Fig-
ure 1) (Ando et al., 2011).
We found that for both the F2CDP- and dATP-inhibited RNR
structures, two a4b4 rings interlocked to form concatenated
(a4b4)2 rings. The observation of concatenated rings was com-
pletely unexpected—the structure was literally tied in knots.
Although concatenated enzyme structures have been reported
in the literature (Lee et al., 2004; Cao et al., 2005), it is unclear
whether these structures were more than crystallographic spacel rights reserved
Figure 1. Structures of E. coli Class Ia RNR
Left: A pseudo-atomic model of the active a2b2
state of E. coli RNR based on SAXS (Ando et al.,
2011). Right: Crystal structure of the dATP-
inactivated a4b4 form of RNR (Ando et al., 2011).
The a2 subunits are shown in cyan/blue, with the
N-terminal domain shown in green and the b2
subunit shown in red/orange. b2 subunit shown in
red/orange with the di-iron center (shown as green
spheres). Residues (shown as black spheres)
along the proposed radical path between Y122
in the b subunit and C439 in the a subunit highlight
how the proposed radical transfer pathway in the
active enzyme is disrupted in the a4b4 ring. Also
labeled are the two types of allosteric effector
binding sites: a specificity site and an activity site.
The specificity site, found at the a dimer interface,
responds to intracellular levels of deoxyribonucleoside 50-triphosphates (dATP, TTP, dGTP) and ATP such that balanced pools of deoxyribonucleotides are
maintained (Reichard, 1988). The activity site found at the N-terminal domain controls the overall enzymatic rate, binding ATP to activate the enzyme or dATP to
turn it off (Larsson and Reichard, 1966a, 1966b; Brown and Reichard, 1969).
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X-ray structures solved in different space groups and used
small-angle X-ray scattering (SAXS) to explore whether concat-
enated rings can form in solution. We also examined what role,
if any, F2CDP plays in the formation of RNR-interlocked rings.
Finally, using electron microscopy (EM), we obtained snapshots
of partially formed RNR rings, providing a glimpse into the ring
assembly process. With so little known about the structures of
holoRNRs and about enzyme concatenation, these data are of
broad interest.
RESULTS
F2CDP-Inhibited and dATP-Inhibited Structures
of E. coli Class Ia RNR
Crystallization using F2CDP treated a2 and b2 subunits in the
presence of ATP has yielded a 4.45 A˚ resolution structure of
this complex, with Rwork/Rfree values of 23.3/26.7 (Table 1). In
this C2221 crystal form, the asymmetric unit contains two a2
dimers and four b monomers (Figure 2A). Applying crystallo-
graphic symmetry operations generates four physiological b2
dimers and results in an (a4b4)2 complex comprising two asym-
metric units (Figure 2C). The a2 dimers are packed near one
another, burying a total surface area of 1,200 A˚2 between the
two dimers (Figure 2E). Each a monomer also makes contacts
to two distinct b2 molecules, one from its own ring, burying
1,500 A˚2 total, and one from the interlocked ring, burying an
additional 160 A˚2 (Figure S1 available online).
The concatenation of two a4b4 rings to make an (a4b4)2
complex is also seen in the 3.95 A˚ resolution structure of
dATP-inhibited E. coli class Ia RNR (Rwork/Rfree of 25.9/28.4). In
this C2 crystal form (Table 1), one a4b4 complex is present in
the asymmetric unit (Figure 2B); however, if two asymmetric
units are shown, a second ring is found to be interlocked
with the first (Figure 2D). While both the F2CDP/ATP structures
and dATP-inhibited structures show two concatenated a4b4
rings, the relative orientation of the rings with respect to each
other is different (Figures 2C and 2D). Consequently, the
packing of the two a2 subunits is not as close in the dATP-
inhibited structure, with only 230 A˚2 of total buried surface areaStructure 20, 1374between the two a2 dimers (Figure 2F compared to Figure 2E),
and each ring is slightly more asymmetric (Figure S1). Again,
each a monomer makes contacts to two distinct b2 molecules,
one from its own ring (Figure 3), burying 1,500 A˚2 total, and
one from an interlocked ring, burying an additional 400 A˚2.
Overall, the (a4b4)2 structures are strikingly similar given the
different space groups and inhibitor/effector combinations
used, indicating that these concatenated rings are formed
reproducibly under a variety of conditions. To test the necessity
of a small molecule inhibitor such as F2CDP or dATP on the
formation of the interlocked ring structure, crystallization was
attempted under the same conditions as the F2CDP/ATP-RNR
structure, but with CDP in place of F2CDP and with an inactive
form of b2 (met-b2). When nucleated with F2CDP/ATP-RNR
microcrystals, these crystallization conditions yield the same
C2221 crystal form, suggesting that small molecule inhibitors
are not essential for this arrangement of molecules in the crystal
lattice (data not shown).
Solution Studies of Concatenated Ring Formation
Previously, we showed that dATP drives the formation of an a4b4
ring that is stable over a wide range of protein concentrations
(2–30 mM) in solution (Ando et al., 2011). Here, we used SAXS
to investigate the effect of F2CDP on the solution conformation
of E. coli RNR. Scattering profiles were obtained from RNR in
the presence of four molar equivalents of F2CDP per a2 and
are shown in Kratky representation (Iq2 versus q) in Figure 4A.
At 10 mM a2 and b2, the Kratky plot is multimodal, with a sig-
nificant peak observed at q0.06 A˚1 (Figure 4A, red), a signa-
ture feature of the nonglobular a4b4 ring (Ando et al., 2011).
Decreasing the protein concentration to 3 mM a2 and b2 led to
a monomodal Kratky plot, indicative of a globular shape (Fig-
ure 4A). A 270 kDa molecular weight estimation obtained by
a Porod invariant method (Fischer et al., 2010) suggests that
this 3 mM sample can be described as a globular a2b2 consistent
with the model in Figure 1, a species previously observed by
SAXS in the absence of dATP (Ando et al., 2011). Linear combi-
nations of theoretical profiles calculated from the a2b2 and a4b4
models shown in Figure 1 yield good fits to the experimental
profiles (Figure 4A). Consistent with our previous observations–1383, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1375
Table 1. X-ray Data Collection and Refinement Statistics
F2CDP/ATP-RNR dATP-RNR
Data collection
Space group C2221 C2
Cell dimensions
a, b, c (A˚) 128.7, 398.9, 319.4 280.5, 155.7, 166.9
a, b, g () 90.0, 90.0, 90.0 90.0, 119.1, 90.0
Wavelength (A˚) 0.9769 0.9794
Resolution (A˚)a 50.0–4.45
(4.61–4.45)
30.0–3.95
(4.09–3.95)
Rsym
a 11.5 (35.7) 16.1 (45.7)
<I/sI>a 8.5 (2.2) 5.0 (2.3)
Completeness (%)a 91.1 (70.6) 96.5 (96.5)
Redundancya 3.8 (2.0) 2.9 (2.9)
Refinement
Resolution (A˚) 49.0–4.45 30.0–3.95
Number of reflections 41,827 52,934
Rwork/Rfree (%) 23.3/26.7 25.9/28.4
Number of atoms
Proteinb 35,053 34,976
Nucleotides 124 348
Fe 8 8
Water 8 8
Average B-factors (A˚2)
Protein 147.8 109.0
Nucleotidesc 171.4 130.0
Fe 121.6 74.8
Water 109.3 89.3
Root-mean-square deviations
Bond lengths (A˚) 0.008 0.02
Bond angles () 1.01 0.74
Protein Data Bank ID 4ERP 4ERM
aValues in parentheses are for the highest-resolution shell.
bA list of residues included in the models is given in Table S1.
cElectron density for modeled nucleotides is shown in Figure S4.
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Structures of Inactivated Ribonucleotide Reductase(Ando et al., 2011), these data indicate that an increase in protein
concentration favors a shift in equilibrium from predominantly
a2b2 to predominantly a4b4.
In a second SAXS experiment, the crystallization precipitant
for the F2CDP/ATP RNR structure [25% polyethylene glycol
(PEG) 3350, 100 mM HEPES (pH 7.5), 200 mM NH4(CH3COO),
5% glycerol] was titrated into 10 mM F2CDP-treated RNR.
Upon addition of precipitant, the shape of the Kratky plot alters
dramatically (Figure 4B). The signature peak of the a4b4 ring
at q0.06 A˚1 decreases relative to the first peak at lower q,
indicative of increasing globularity with increasing precipitant.
This change in shape is concomitant with an increase in overall
radius of gyration from 69 to 77 A˚, exceeding the previously
determined value for the a4b4 ring (71.1 A˚) (Ando et al., 2011).
Unsurprisingly, two-component linear combinations of a2b2
and a4b4 species described above were insufficient to describe
the data. Good fits were obtained by the inclusion of an (a4b4)2
species in the linear combinations (Figure 4B, black curves)1376 Structure 20, 1374–1383, August 8, 2012 ª2012 Elsevier Ltd Alyielding the fractions of each species (Figure 4C). Here, the rela-
tive orientations of the rings seen in the dATP-inhibited structure
provided a better fit to the solution data than those observed in
the F2CDP/ATP structure.
Because experimental scattering profiles are obtained at
finite protein concentrations and therefore are not devoid of
excluded volume effects, molar fractions extracted from fitting
theoretical profiles are not precise quantities. Thus, the obser-
vation of a trend across the titration series is essential. The
trends observed in Figure 4C provide strong support that the
a4b4 species is used to form the (a4b4)2 species. Together, these
data are consistent with the addition of crystallization precipi-
tant facilitating the conversion of nonglobular ring species to
interlocked rings that are larger in size and more globular.
EM Analysis Shows Population of Partial Ring
Intermediates
The formation of (a4b4)2 species from a4b4 rings suggests that
these RNR rings must be flexible or come apart. To explore
this issue, we analyzed EM images of a2 and b2 (150 nM) in the
presence of inhibitor dATP (50 mM). At these low protein concen-
trations, no (a4b4)2 species are expected, and we found that the
complexes are a mixture of completely closed a4b4 rings and
partially formed species. Previously, we focused our analysis
of these EM images on investigating the structure of the domi-
nant species, the fully assembled dATP-inhibited a4b4 RNR
ring (Ando et al., 2011), while here we were interested in extend-
ing the analysis to include the partially assembled rings. EM
images of RNR oligomers were aligned and clustered by simi-
larity, resulting in 33 classes of RNR complexes with different
composition and structure. Approximately 56% of particles (in
14 of 33 classes) form completely closed a4b4 rings in the
presence of 50 mM dATP, while other class averages reveal
broken rings in which one connection between adjacent a2 and
b2 dimers is severed (19% of particles) and partial rings with
a missing b2 subunit (19% of particles) (Figure 5 and Figure S2).
The open and partial rings may represent assembly or dis-
assembly intermediates and, together with the asymmetry ob-
served in many of the closed rings, suggest that the connections
between a2 and b2 can be readily formed and broken.
Comparison between the class averages suggests a hinge
motion in the a-b interaction. By overlaying the class variance
images and the class averages, additional heterogeneity is
apparent within each class, particularly those classes with
severed a-b connections (Figure S2). Thus the conformations
captured by EM class averages appear to represent samples
along a continuum of motion in the a-b interface. To assess the
degree of flexibility in the a-b interaction, atomic models of a2
and b2 were fitted into three-dimensional maps of the structures
represented by the severed-ring EM classes. Each interacting
a-b pair from both the EM reconstructions (Figure 5B) and from
the two crystal structures (Figure 2) was aligned and compared.
This analysis reveals that the a-b orientation within the closed
a4b4 rings varies by up to 7
, and that a-b interfaces in the less
constrained open conformations can readily accommodate
motions of 10–25 (Figures 5D and 5E). Such elasticity of the
a4b4 ring would seem to be required both for conversion of an
a4b4 inactive state into an active a2b2 species of RNR, as well
as for the formation of the (a4b4)2 interlocked rings.l rights reserved
Figure 2. Multiple Crystal Forms Display
Interlocked a4b4 Rings for E. coli RNR
Each a4b4 ring is colored separately, with the
F2CDP/ATP-RNR complex in blue/yellow and the
dATP-RNR complex in green/purple.
(A and B) One asymmetric unit for each complex is
shown as ribbons with a transparent surface and
a full surface for the F2CDP/ATP and dATP-RNR
complexes, respectively.
(C and D) The full (a4b4)2 RNR complex is shown
from the front and from the side for each complex.
(E and F) A top view of each RNR complex shows
the packing of two a2 dimers (left) and a close-up
of interactions of just the a2 dimers in an identical
orientation (right). Other known structures with
interlocked rings are shown in Figure S3.
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Structures of Inactivated Ribonucleotide ReductaseDISCUSSION
Despite the significant interest in RNRs due to their sophisticated
allosteric regulation and success as drug targets, the interac-
tions between the a2 and b2 subunits of the class Ia enzymes
have been challenging to visualize. Here we present two X-ray
structures of the prototypic E. coli RNR enzyme that display
interactions between both subunits. These structures represent
inhibited forms of RNR, one inhibited with the chemotherapeutic
agent F2CDP and the other bound with the negative allosteric
regulator dATP. Unexpectedly, structure data show that the
subunits are arranged into two interlocked a4b4 rings. AlthoughFigure 3. Detailed View of the a-b Interface within an a4b4 Ring
The protein is shown as ribbons, with residues found near the interface shown
as sticks. The residue names and numbers are labeled. The a subunit is
colored in green and the b subunit is colored in orange (carbons are the same
color as the ribbon; oxygen is red, nitrogen is blue) with dATP bound at the
activity site in sticks (carbon is yellow, oxygen is red, nitrogen is blue, phos-
phorus is orange). Additional close-up views of interfaces and distances
between the a2 and b2 subunits are shown in Figure S1.
Structure 20, 1374–1383, August 8, 2012 ªrare, two concatenated protein structures
have been described previously (Lee
et al., 2004; Cao et al., 2005). In particular,
RecR, an enzyme involved in homologous
recombinational DNA repair, forms inter-locked tetrameric-ring structures in its crystal lattice (Figure S3).
Since DNA is proposed to bind in the center of one RecR
tetrameric ring, the presence of the second interlocked ring is
not thought to be physiologically relevant (Lee et al., 2004).
However, the ability of RecR tetramers to interlock may indicate
a propensity of these rings to open and close, an important
aspect of its DNA binding function. Thus two of the three concat-
enated protein structures involve tetrameric ring structures that
are either known or have been proposed to open and close as
part of their cellular activities.
The other example of interlocked protein rings was found
with bovine mitochondrial peroxiredoxin III, which forms
magnificent concatenated dodecameric structures (Cao et al.,
2005) (Figure S3). Here it is not known which state of the
enzyme is active, or why such a multimeric complex might
form. For both RecR and peroxiredoxin III, data are not avail-
able to firmly establish whether these interlocked structures
form in solution, although the authors of the peroxiredoxin
studies (Cao et al., 2005) mention preliminary analytical ultra-
centrifugation data that suggest some formation of concate-
nated rings in solution. Also, while mechanisms of protein ring
concatenation have been considered for both RecR and perox-
iredoxin III, experimental support is unavailable (Lee et al.,
2004; Cao et al., 2005).
To address the conditions under which interlocked protein
rings can form in a crystal lattice, we investigated whether
F2CDP was required in the E. coli RNR crystallization solution
for the formation of the C2221 crystal arrangement of concate-
nated rings. We found that it was not required, consistent with
the mode of F2CDP inhibition necessitating active enzyme (the
a2b2 state). Instead, the requisite high protein concentrations
for crystallization can explain the formation of a4b4 rings in the
C2221 cell. Structural data also show that the (a4b4)2 state can
form in a C2 crystal form in the presence of inhibitor dATP,
known to form the a4b4 ring. Thus, despite the different crystalli-
zation conditions and inhibitors used, E. coli RNR preferentially
form interlocked rings in the crystalline state.2012 Elsevier Ltd All rights reserved 1377
Figure 4. SAXSStudies on F2CDP-Treated E. coliRNRReveal Condi-
tions Important for Oligomeric State Changes
(A) Kratky plots of 3 mM (gray) and 10 mM (red) F2CDP- treated E. coli RNR. The
presence of one large peak at 3 mMRNR indicates a globular species, such as
a2b2, while the presence of two peaks at 10 mM RNR indicates a nonglobular
species, such as the a4b4-ring. A two-component fit to the data (curved black
line) indicates that the solution at 3 mMRNR is 94% a2b2 and 6% a4b4, while the
solution at 10 mM RNR is 43% a2b2 and 57% a4b4.
(B) The Kratky representation of 10 mM F2CDP-treated RNR over the course of
a titration with 0%–50% v/v crystallization precipitant indicates a shift from
a less globular species, such as an a4b4-ring, to a more globular species, such
as (a4b4)2. The movement of the first peak from the dotted line to lower q is
consistent with an increase in overall radius of gyration.
(C) A three-component fit to the data (curved black lines in B) yields the
fractions of a2b2 (black dotted line), a4b4 (red dotted line), and (a4b4)2 (blue
Structure
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1378 Structure 20, 1374–1383, August 8, 2012 ª2012 Elsevier Ltd AlThe solution-based technique SAXS was employed to
examine whether interlocked rings form in solution. Consistent
with the above observations from crystallography, the presence
of F2CDP was not the determinant for concatenation of E. coli
RNR rings. Instead, the primary determinant was the presence
of ingredients from the crystallization precipitant [25% PEG
3350, 100 mM HEPES (pH 7.5), 200 mM NH4(CH3COO), 5%
glycerol]. Interestingly, one ingredient, PEG, is a well-known
molecular crowding agent (Ellis, 2001; Minton, 2000; Zhou
et al., 2008) that often favors high-order oligomerization
(Hamiaux et al., 2000). A dramatic shift from a4b4 to (a4b4)2
was observed upon addition of precipitant (Figure 4B), providing
the first unambiguous experimental support that concatenated
rings can form in solution.
It is intriguing that the subunits of the a4b4 ring did not rear-
range into compact assemblies in the presence of a crowding
agent such as PEG, but rather the ring retained its hole (with
a diameter of 80 A˚), and that hole was filled with a second
doughnut-like ring. The preference to respond to ‘‘crowding’’
with concatenation of individual a4b4 rings rather than by subunit
rearrangement is surprising in that RNRs from other species,
such as yeast, will form larger complexes (a6b2) (Fairman et al.,
2011). Despite the similarity in the structure of the yeast and
E. coli a2 subunits (Uhlin and Eklund, 1994; Xu et al., 2006), the
E. coli enzyme does not form a-hexamers. The only complexes
larger than the active a2b2 state that E. coli RNR appears to
form are a4b4 or when ‘‘crowded’’ (a4b4)2.
A significant remaining question is how concatenated rings
form. Three mechanisms can be considered (Lee et al., 2004;
Cao et al., 2005). In the first mechanism, one ring is formed
and the second ring is assembled around the first ring. In the
second mechanism, two rings simultaneously become inter-
locked due to association of monomers from distinct rings
before the assembly process is complete. In the third mecha-
nism, a ring opens, embraces a second ring, and recloses.
Our SAXS data favor the third mechanism. In particular, the
SAXS data show that in the presence of precipitant, the frac-
tion of a2b2 remains fairly constant, while the fraction of a4b4
decreases significantly as the (a4b4)2 species develops (Fig-
ure 4C). This observation indicates that interlocked rings form
from a2 and b2 subunits that were previously part of single rings.
While rings could come apart completely, with subunits reas-
sembling around an intact ring or assembling simultaneously to
form interlocked rings, it is difficult to explain why the amount
of a2b2 species would not be more dramatically affected in
such a case. Thus, this SAXS result is more consistent with the
third mechanism, in which rings open and reclose. In addition,
EM images of E. coli RNR with inhibitor dATP show that 19%
of the particles are a4b4 rings that have opened to varying
degrees (Figure 5), depicting the flexibility necessary for this
mechanism of concatenation (Movie S1).
It is also interesting to consider whether there might be
a benefit to the formation of E. coli RNR concatenated rings
in vivo. Phrased another way, could the formation of interlocked
rings be a further means of cellular RNR activity modulation?dotted line) species present at the indicated percentages of precipitant. The
data suggest that precipitant favors the formation of (a4b4)2 from a4b4.
l rights reserved
Figure 5. EM Analysis of dATP-Inhibited RNR Reveals Flexibility in the a4b4 Ring
(A) Class averages of a closed a4b4 ring (right) and a4b4 in opened-ring conformations with severed interaction between the a2 and b2 subunits.
(B) Three-dimensional reconstructions for each class with fit atomic structures (Protein Data Bank ID 4R1R and 1RIB) illustrate the flexibility in the a2-b2 interface
(see also Movie S1).
(C) The conformational distribution of particles based on the entire set of 33 class averages (see also Figure S2).
(D) Interacting a-b pairs from the fitted models in (B) and from dATP and F2CDP-inhibited RNR crystal structures, aligned using the a subunits (blue, with the
N-terminal domain in green). Rotations of the b subunits from the crystal structures (red) or from the EM structures (orange) weremeasured relative to chain E from
the dATP-inhibited RNR crystal structure (arrowheads).
(E) Red lines indicate the rotation measured for each a-b pair from the crystal structures. The histogram (orange bars) presents the angular distribution of a-b
interactions observed in the EM reconstructions.
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Structures of Inactivated Ribonucleotide ReductaseWhile the production of deoxynucleotides by RNR is essential for
DNA biosynthesis and repair, overproduction can be detrimental
(Wheeler et al., 2005), requiring all organisms including E. coli to
adopt cellular processes to both upregulate and downregulate
RNR activity (Elledge et al., 1993). The modulation of E. coli
RNR activity by ATP and dATP levels, which involves the binding
of ATP/dATP to the activity sites on a2 and the subsequent equi-
librium shift between active a2b2 and inactive a4b4 states,
provides a sensitive and efficient method for both upregulationStructure 20, 1374and downregulation of RNR function (Brown and Reichard,
1969; Rofougaran et al., 2008; Ando et al., 2011). The higher
resolution structure of dATP-inhibited RNR presented here
allowed us to identify residues at this key a-b interface near
the activity site within the a4b4 complex (Figure 3). Although polar
residues such as Trp, Ser, Glu, and His line these surfaces,
providing some potential for hydrogen bonding interactions,
the overall contact area was small (Figure 3), consistent with
the ability of E. coli RNR to efficiently sever these interactions–1383, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1379
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Structures of Inactivated Ribonucleotide Reductaseand convert to an active state in response to ATP. While this
small contact area allows for a facile conversion from an inactive
state, there could be cellular conditions in which it would be
desirable to maintain RNR in an inactive state that does not
directly interconvert with active enzyme. One can imagine
a scenario in which an abundance of a4b4 rings formed under
high dATP cellular conditions might lead to interlocked (a4b4)2
rings in a crowded cellular milieu. The sequestration of a2 and
b2 into these interlocked rings would limit their dissociation,
slowing their transition back to an active enzyme state. The addi-
tional disassembly of (a4b4)2 into single a4b4 rings before con-
version back to active a2b2 would then lead to a more gradual
increase in the levels of deoxynucleotides. Whether such a
mechanism of regulation exists and what would drive such a
transformation in vivo requires further study.
Finally, with recent 6.6 A˚ resolution X-ray data for yeast RNR
revealing hexameric a subunit ring-like structures in the pres-
ence of dATP (Fairman et al., 2011), it is apparent that attention
must be paid to the propensity of multiple RNRs to form rings.
While the contributions of particular residues to the stability of
the protein-protein interfaces within these rings remains to be
determined, it is interesting to note that the residues on the
E. coli a nearest the a-b interface (Figure 3) are not conserved,
evenwithin bacterial species. Exploiting differences in ring struc-
tures may offer new strategies to inhibit RNRs in a species-
specific manner. Clearly, the ability of RNR subunits to form
and break interactions at interfaces is key to allosteric regulation
of activity, and we now find that this subunit flexibility can even
lead to the formation of interlocked rings. In particular, the
work presented here demonstrates that the a4b4 rings formed
by the E. coli enzyme have the proclivity to concatenate in the
presence of crowding agents. With conclusive evidence for
formation of these interlocked rings in solution, our SAXS and
EM data also provide some of the first experimental data to
address the mechanism of protein ring concatenation. While
beautiful to observe, these concatenated rings appear to be
more than a crystallization magic trick. We now understand the
relationship between the previously determined a4b4 dATP-
inhibited state of E. coli RNR and this interlocked ring system,
with information about when and how these concatenated rings
can form.
EXPERIMENTAL PROCEDURES
Reagent Preparation
Cytidine 5’-diphosphate was purchased from Sigma-Aldrich and was dis-
solved into assay buffer (50 mM HEPES [pH 7.6], 15 mM MgCl2, 1 mM
EDTA). The pH was slowly adjusted to 7-8 with NaOH, and the concentration
was determined spectroscopically using ε271 of 9.1 mM
1cm1. High-purity
solutions of ATP and dATP were purchased from USB Corporation. F2C was
a gift from Eli Lilly. F2CDP was prepared as described (Artin et al., 2009).
Protein Preparation
The a2 and b2 proteins were prepared as described (Salowe and Stubbe,
1986; Salowe et al., 1987). The concentrations of a2 and b2 were determined
using ε280 of 189 and 131 mM
1cm1, respectively; all molar concentrations
are dimer concentrations (i.e., a2 or b2).
Crystallization of F2CDP-Inactivated RNR
The F2CDP-inactivation reaction was performed immediately before crystalli-
zation by supplementing a protein mixture (31 mM a2 and 62 mM b2 in 50 mM1380 Structure 20, 1374–1383, August 8, 2012 ª2012 Elsevier Ltd AlHEPES, 15 mMMgCl2 1 mM EDTA [pH 7.6]) with 3 mM ATP and 5 mM dithio-
threitol (DTT) and 120 mM F2CDP, and incubating in a 25
C water bath for
10min prior to crystallization. The F2CDP inactivated complex was crystallized
by adding 2 ml of the protein mixture to 4 ml of precipitant solution [25% PEG
3350, 100 mM HEPES (pH 7.5), 200 mM NH4(CH3COO), 5% glycerol] and
equilibrating over a 500 ml reservoir of precipitant solution at room tempera-
ture. To grow crystals large enough for data collection, drops were streak
seeded from crushed crystals grown in similar conditions. Crystals appeared
after 1 week and continued to grow for several weeks. Crystals were cryo-
cooled by adding 5 ml of solution containing 25% PEG 3350, 100 mM HEPES
(pH 7.5), 200 mM NH4(CH3COO), and 20% glycerol to the drop containing
crystals, then looping out of this drop after 1–3 min and plunging directly in
liquid N2. Diffraction data were collected at the Cornell High Energy Synchro-
tron Source (CHESS) beamline A1 at 100 K and were processed using
HKL2000 (Otwinowski and Minor, 1997) (Table 1).
Crystallization of dATP-inactivated RNR
For the dATP structure, hydroxyurea-inactivated b2 (met-b2) was used in place
of active b2. Met-b2 was prepared from purified active b2 as described (Ando
et al., 2011). Crystals were grown by adding 1 ml of protein (25 mM a2 and
50 mM met-b2 in 50 mM HEPES, 15 mM MgCl2, 1 mM EDTA [pH 7.6] supple-
mented with 10 mM dATP and 5 mM DTT) to 1 ml of precipitant solution [10%
PEG 3350, 100 mM 3-morpholinopropane-1-sulfonic acid (MOPS; pH 7.5),
200 mM Mg(CH3COO)2, 25 mM MgCl2, 6 mM n-nonyl-b-D-maltopyranoside
(Hampton Research) and 5% glycerol] and equilibrating over a 500 ml reservoir
of precipitant without n-nonyl-b-D-maltopyranoside at room temperature.
Crystals were cryo-cooled after 1 week by looping through solutions of
13% PEG 3350, 100 mM MOPS (pH 7.5), 200 mM Mg(CH3COO)2, 40 mM
MgCl2, 5 mM DTT, 10 mM dATP, and successive concentrations of 10%,
15%, and 20% glycerol and plunged directly in liquid N2. Diffraction data
were collected at the Advanced Photon Source at Argonne National Labs on
beamline 24ID-C at 100 K and processed using HKL2000 (Otwinowski and
Minor, 1997) (Table 1).
Structure Solution and Refinement
The initial F2CDP-RNR structure was solved with a lower resolution data set by
molecular replacement in the program PHASER (McCoy et al., 2007) using
previously solved structures of a and b monomers with no ligands included
as search models (Protein Data Bank ID 1RLR [Uhlin and Eklund, 1994] and
1PFR [Logan et al., 1996], respectively). After higher resolution data was ob-
tained, initial refinement of the F2CDP structure was done using Fourier syn-
thesis methods. The dATP-RNR structure was solved using Fourier synthesis
methods from the previously published 5.65 A˚ structure (Ando et al., 2011). For
both structures, iterative rounds of data refinement and model building were
performed in CNS 1.3 (Bru¨nger et al., 1998) and COOT (Emsley et al., 2010),
respectively. Refinement consisted of rigid-body, low-temperature (300 K)
simulated annealing using deformable elastic network restraints (Schro¨der
et al., 2010) and group B-factor refinement with two B-factors per residue,
one for main-chain atoms and one for side-chain atoms. During all rounds of
refinement, loose noncrystallographic symmetry restraints were used.
Final Model of F2CDP/ATP-RNR
At 4.45 A˚ resolution, secondary structure can be unambiguously assigned,
while side-chain positions are not well defined. Side chains are included in
the model based on their positions in previously solved high-resolution struc-
tures; however, their high B-factors (average of 147.8) indicate the positions
are not precisely determined. In the F2CDP-RNR structure, there is some posi-
tive density in all four catalytic sites where the inhibitor would be expected to
bind and react (Figure S4). Because we do not know the identity of the reaction
product and the resolution of the data is too poor to distinguish possible prod-
ucts, nothing hasbeenmodeled in these sites. The catalytic site of thea subunit
contains two redox active cysteine residues that are oxidized to a disulfide
during the reaction (Thelander, 1974; Uhlin and Eklund, 1994). All four catalytic
site disulfide pairs appear to be reduced. All residues present in the model are
listed in Table S1 with refinement statistics in Table 1. In addition, the model
contains ATP at all four activity sites as well as 2 Fe3+ atoms with a bridging
oxygen and 2 Fe ligated H2Os in each b chain. Positive difference density at
the di-iron center could be accounted for by modeling the bridging oxygenl rights reserved
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high-resolution structures of the b subunit. After including them in the model,
all difference density was accounted for, showing that even at this relatively
low resolution, we can detect water bound at the di-iron center. In the
Ramachandran plot, 90.3%, 9.6%, 0.1%, and 0.0% of residues are in favored,
allowed, generously allowed, and disallowed regions, respectively.
Final Model of dATP-RNR
All residues present in the 3.95 A˚ resolution dATPmodel are listed in Table S1,
with refinement statistics listed in Table 1. The model contains dATP at all four
specificity sites and all four activity sites (Figure S4). In addition, density was
seen in all four catalytic sites. Only diphosphates bind at the catalytic site, but
no diphosphates were added to the crystallization; therefore, dADP, a likely
contaminant of dATP and product of RNR, was modeled in this site (Fig-
ure S4). In addition, two Fe3+ atoms with a bridging oxygen and two Fe-ligated
H2Os are present in each b chain, modeled as described for the F2CDP-RNR
structure. In the Ramachandran plot, 90.2%, 9.8%, 0.0%, and 0.0% of resi-
dues are in favored, allowed, generously allowed, and disallowed regions,
respectively.
SAXS of F2CDP-Inactivated RNR
The F2CDP-inactivation reaction was conducted immediately prior to SAXS
data collection. A protein mixture (30 mM a2 and 30 mM b2 in assay buffer
[50 mM HEPES, 15 mM MgCl2, 1 mM EDTA (pH 7.6)]) was supplemented
with 3mMATP, 5mMDTT, and 120 mMF2CDP (final concentrations) and incu-
bated in a 25Cwater bath for 10 min. In the precipitant titration experiment, in
order to mimic crystallization conditions, the 30 mM inactivated mixture was
diluted 3-fold with precipitant mixtures [25% PEG 3350, 100 mM HEPES
(pH 7.5), 200 mM NH4(CH3COO), 5% glycerol] that were diluted with water
to give the total v/v precipitant concentration indicated. To obtain data at
3 mMRNR, the 30 mMstock solution was diluted 10-fold with assay buffer con-
taining 3 mM ATP and 5 mM DTT.
SAXS was performed at the CHESS G1 station using a 9.5 keV 250 mm
square X-ray beam with a flux of several 1012 photons/s/mm2. Data were
collected on a custom 1024 3 1024 pixel CCD detector (Tate et al., 1995)
with a sample-to-detector distance of 2 m. The transmitted intensity was
measured on a PIN diode beamstop (Ando et al., 2008). Protein solutions
and reference solutions were prepared such that the buffer contents matched.
Samples were contained in 2 mm path length acrylic cells (ALine Inc.) (Ando
et al., 2008) with 7.5 mm kapton windows (Chemplex). The same cell was used
for acquisition of protein solution and background scattering pairs. Several 1
and 2 s exposures were taken per sample separated by 10 s pauses. The scat-
tering images were corrected and integrated about the beam center following
previously described image correction procedures (Ando et al., 2008). Expo-
sures that did not display apparent radiation-induced changes were averaged
and normalized by the transmitted intensities. Background scattering was
subtracted from the protein solution scattering to produce the one-dimen-
sional protein scattering profile, I(q), as a function of q, where q = 4p/l sin q;
2q is the scattering angle, and l is the X-ray wavelength.
Theoretical scattering curves were calculated from atomic coordinates
using CRYSOL (Svergun et al., 1995). Here, the resulting forward scattering
intensities [I(q) at q = 0] are proportional to the square of themolecular weights.
Linear combinations of theoretical scattering curves, Ifit(q), were fitted to SAXS
data using least-squares fitting in MATLAB:
IfitðqÞ= c
XN
i
fi IiðqÞ;
where Ii(q) and fi are the scattering curve andmolar fraction for the i-th species,
N is the number of species, and c is a constant scaling factor.
The average globularity of the species in solution was investigated by Kratky
analysis (Glatter and Kratky, 1982). Here, the scattering profile is plotted as Iq2
versus q to emphasize the power-law dependence in the mid-q range. I(q) of
globular, folded species displayed a q4 dependence in this range, giving
rise to a single prominent peak in the Kratky plot. Multiple distinct peaks in a
Kratky plot are observed in the case of proteins with multiple domains in a
nonglobular arrangement (Bernado´, 2010), as in the inhibited a4b4 RNR struc-
ture (Ando et al., 2011).Structure 20, 1374EM of dATP-Inhibited RNR
For EM studies, met-b2 was used in place of active b2. A total of 150 nM a2 and
met-b2 were combined with 1 mM CDP and 50 mM dATP in assay buffer. We
then applied 5 ml of the mixture to a carbon-coated EM grid that had been
glow discharged immediately before use. The grid was washed three times
with a stain solution containing 2% uranyl acetate (Ted Pella) and 0.2% treha-
lose, and then a second carbon layer was applied (Tischendorf et al., 1974).
Eighty-nine pairs of CCD images were collected of the 55 tilted and untilted
specimen at 50,0003 magnification and 120 kV on a Tecnai F20 microscope
(FEI) operated manually using Leginon (Suloway et al., 2005) to store the
images. CCD frames have a pixel size of 2.18 A˚ at the specimen level.
Ring and C-shaped particles were selected from the untilted images using
EMAN2’s e2boxer.py (Tang et al., 2007), and TiltPicker (Voss et al., 2009)
was modified to import and transform the coordinates onto the tilted images.
A total of 14,055 pairs of particles were windowed, and 160 particles were
removed from the dataset after an initial reference-free alignment and classi-
fication as members of four poor-quality classes. An iterative alignment and
supervised classification routine was then repeated on the remaining 13,895
particles using SPIDER as described previously (Brignole et al., 2009), result-
ing in 33 classes. Three-dimensional density maps were reconstructed for
each class using CTF-corrected tilted particles (Radermacher et al., 1987; Ra-
dermacher et al., 2001) supplemented with a random selection of 10% of the
untilted particles (Fairman et al., 2011). Each reconstruction was low-pass
filtered at its resolution as determined by the Fourier shell correlation at 0.5.
The reconstructions were interpreted by iterative rigid fitting crystal struc-
tures of a2 (4R1R) (Eriksson et al., 1997) and b2 (1RIB) (Nordlund and Eklund,
1993) using UCSF Chimera’s ‘‘fitmap’’ command (Goddard et al., 2007).
When compared with the fit structures and our a4b4 crystal structures, the
EM density maps appeared compressed in the dimension perpendicular to
the carbon support film by a factor of 1/3, a well-documented artifact of
specimen preservation in negative stain (Cheng et al., 2006; Kellenberger
et al., 1982). Despite the flattening, contours of the crystal structures could
be clearly recognized on the upper and lower surfaces of the EM recon-
structions, indicating that the features had been merely compressed in the
z-dimension. To compensate for the compression artifact, density maps
were stretched to voxel dimensions of 4.36 3 4.36 3 6.54 A˚ and the fitting
of individual subunits was refined. Interacting a-b pairs were extracted from
the fitted models and from the a4b4 crystal structures, and the a subunits of
each pair were superimposed in Chimera. Relative motions of the b subunits
were calculated with Chimera’s ‘‘measure rotation’’ command (Goddard
et al., 2007). Chain E of the dATP crystal structure was chosen as the frame
of reference because this chain has an intermediate conformation among
the b subunits extracted from the a4b4 crystal structures.
An animation that illustrates the observed conformational flexibility was
generated using the ‘‘Morph Conformations’’ tool in Chimera to interpolate
between the coordinates of models shown in Figure 5 (Movie S1).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one movie, and one table and
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